Neuropsychobiology

Original Paper

Further Evidence of the Positive Influence of Repetitive Transcranial Magnetic Stimulation on Speech and Language in Patients with Aphasia after Stroke: Results from a Double-Blind Intervention with Sham Condition

Haghighi M.a · Mazdeh M.a · Ranjbar  N.a · Seifrabie M.A.b

Author affiliations

aResearch Center for Behavioral Disorders and Substance Abuse, Hamadan University of Medical Sciences, Hamadan, Iran
bDepartment of Social Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Related Articles for ""

Neuropsychobiology 2017;75:185–192

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 07, 2017
Accepted: November 30, 2017
Published online: January 16, 2018
Issue release date: April 2018

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 2

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Abstract

Background: After a stroke, up to 20% of patients suffer from aphasia. The preferred treatment for stroke-related aphasia (SRA) is regular speech and language training (SLT). In the present study, we investigated to what extent adjuvant repetitive transcranial magnetic stimulation (rTMS) might enhance recovery. While there is growing evidence of the positive effect of adjuvant rTMS on aphasia, no study has yet been based on an Iranian sample. Method: A total of 12 patients (mean age: 55 years; right-handed; 7 women) underwent treatment for SRA 1 month after stroke. The standard treatment consisted of regular 45-min SLT sessions 5 times a week for 2 consecutive weeks. Additionally, patients were randomly assigned either to adjuvant rTMS (5 times a week for 30 min) or to a sham condition (5 times a week for 30 min). At baseline and after 2 weeks of intervention, the degree of aphasia was assessed with the Farsi version of the Western Aphasia Battery. rTMS was applied to the inferior posterior frontal gyrus of the right hemisphere. Results: Speech and language improved over time, but more so in the rTMS than in the sham condition. Large effect sizes were observed for content, fluency, and the aphasia quotient; medium effect sizes were observed for command comprehension and repetition, while effect sizes were small for auditory comprehension and naming. Conclusions: Among patients with SRA, compared to a sham condition, adjuvant rTMS improved speech and language skills. The present results add to the accumulating evidence that rTMS as a neuromodulation technique has the capacity to enhance the effect of conventional SLT.

© 2018 S. Karger AG, Basel




Related Articles:


References

  1. Pedersen PM, Vinter K, Olsen TS: Aphasia after stroke: type, severity and prognosis. The Copenhagen Aphasia Study. Cerebrovasc Dis 2004; 17: 35–43.
  2. Wade DT, Hewer RL, David RM, Enderby PM: Aphasia after stroke: natural history and associated deficits. J Neurol Neurosurg Psychiatry 1986; 49: 11–16.
  3. Code C, Petheram B: Delivering for aphasia. Int J Speech Lang Pathol 2011; 13: 3–10.
  4. Zumbansen A, Thiel A: Recent advances in the treatment of post-stroke aphasia. Neural Regen Res 2014; 9: 703–706.
  5. Brady MC, Kelly H, Godwin J, Enderby P, Campbell P: Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2016; 6:CD000425.
  6. Breitenstein C, Grewe T, Floel A, Ziegler W, Springer L, Martus P, Huber W, Willmes K, Ringelstein EB, Haeusler KG, Abel S, Glindemann R, Domahs F, Regenbrecht F, Schlenck KJ, Thomas M, Obrig H, de Langen E, Rocker R, Wigbers F, Ruhmkorf C, Hempen I, List J, Baumgaertner A: Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet 2017; 389: 1528–1538.
  7. Fridriksson J, Hubbard HI, Hudspeth SG: Transcranial brain stimulation to treat aphasia: a clinical perspective. Semin Speech Lang 2012; 33: 188–202.
  8. Heiss WD, Hartmann A, Rubi-Fessen I, Anglade C, Kracht L, Kessler J, Weiduschat N, Rommel T, Thiel A: Noninvasive brain stimulation for treatment of right- and left-handed poststroke aphasics. Cerebrovasc Dis 2013; 36: 363–372.
  9. Thiel A, Hartmann A, Rubi-Fessen I, Anglade C, Kracht L, Weiduschat N, Kessler J, Rommel T, Heiss WD: Effects of noninvasive brain stimulation on language networks and recovery in early poststroke aphasia. Stroke 2013; 44: 2240–2246.
  10. Mally J: Non-invasive brain stimulation (rTMS and tDCS) in patients with aphasia: mode of action at the cellular level. Brain Res Bull 2013; 98: 30–35.
  11. Kapoor A: Repetitive transcranial magnetic stimulation therapy for post-stroke non-fluent aphasia: a critical review. Top Stroke Rehabil 2017; 24: 547–553.
  12. Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipovic SR, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L: Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol 2014; 125: 2150–2206.
  13. Haghighi M, Shayganfard M, Jahangard L, Ahmadpanah M, Bajoghli H, Pirdehghan A, Holsboer-Trachsler E, Brand S: Repetitive transcranial magnetic stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD – results from a single-blind, randomized clinical trial with sham cross-over condition. J Psychiatr Res 2015; 68: 238–244.
  14. Jahangard L, Haghighi M, Shyayganfard M, Ahmadpanah M, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S: Repetitive transcranial magnetic stimulation (rTMS) improved symptoms of obsessive compulsive disorders (OCD), but also cognitive performance? Results from randomized clinical trial with cross-over design and sham-condition. Neuropsychobiology 2016; 17: 224–232.
  15. Ridding MC, Rothwell JC: Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci 2007; 8: 559–567.
  16. Wong IS, Tsang HW: A review on the effectiveness of repetitive transcranial magnetic stimulation (rTMS) on post-stroke aphasia. Rev Neurosci 2013; 24: 105–114.
  17. Garcia G, Norise C, Faseyitan O, Naeser MA, Hamilton RH: Utilizing repetitive trans­cranial magnetic stimulation to improve language function in stroke patients with chronic non-fluent aphasia. J Vis Exp 2013; 77:e50228.
  18. Naeser MA, Martin PI, Ho M, Treglia E, Kaplan E, Bashir S, Pascual-Leone A: Transcranial magnetic stimulation and aphasia rehabilitation. Arch Phys Med Rehabil 2012; 93:S26–S34.
  19. Martin PI, Naeser MA, Ho M, Treglia E, Kaplan E, Baker EH, Pascual-Leone A: Research with transcranial magnetic stimulation in the treatment of aphasia. Curr Neurol Neurosci Rep 2009; 9: 451–458.
    External Resources
  20. Naeser MA, Martin PI, Treglia E, Ho M, Kaplan E, Bashir S, Hamilton R, Coslett HB, Pascual-Leone A: Research with rTMS in the treatment of aphasia. Restor Neurol Neurosci 2010; 28: 511–529.
  21. Balossier A, Etard O, Descat C, Vivien D, Emery E: Epidural cortical stimulation as a treatment for poststroke aphasia: a systematic review of the literature and underlying neurophysiological mechanisms. Neurorehabil Neural Repair 2016; 30: 120–130.
  22. Nicolo P, Fargier R, Laganaro M, Guggisberg AG: Neurobiological correlates of inhibition of the right Broca homolog during new-word learning. Front Hum Neurosci 2016; 10: 371.
  23. Barwood CH, Murdoch BE, Whelan BM, Lloyd D, Riek S, O’Sullivan JD, Coulthard A, Wong A: Improved language performance subsequent to low-frequency rTMS in patients with chronic non-fluent aphasia post-stroke. Eur J Neurol 2011; 18: 935–943.
  24. Barwood CH, Murdoch BE, Whelan BM, Lloyd D, Riek S, O’Sullivan J, Coulthard A, Wong A, Aitken P, Hall G: The effects of low frequency repetitive transcranial magnetic stimulation (rTMS) and sham condition rTMS on behavioural language in chronic non-fluent aphasia: short term outcomes. Neurorehabilitation 2011; 28: 113–128.
  25. Nilipour R, Pourshahbaz A, Ghoreyshi ZS: Reliability and validity of bedside version of Persian WAB (P-WAB-1). Basic Clin Neurosci 2014; 5: 253–258.
    External Resources
  26. Kertesz A: Western Aphasia Battery-Revised (WAB-R): Examiner’s Manual. San Antonio, PsychCorp Harcort Assessment Incorporation, 2006.
  27. Thiel A, Zumbansen A: The pathophysiology of post-stroke aphasia: a network approach. Restor Neurol Neurosci 2016; 34: 507–518.
  28. Winhuisen L, Thiel A, Schumacher B, Kessler J, Rudolf J, Haupt WF, Heiss WD: Role of the contralateral inferior frontal gyrus in recovery of language function in poststroke aphasia: a combined repetitive transcranial magnetic stimulation and positron emission tomography study. Stroke 2005; 36: 1759–1763.
  29. Shayganfard M, Jahangard L, Nazaribadie M, Haghighi M, Ahmadpanah M, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S: Repetitive transcranial magnetic stimulation improved symptoms of obsessive-compulsive disorders but not executive functions: results from a randomized clinical trial with crossover design and sham condition. Neuropsychobiology 2016; 74: 115–124.
  30. Dollfus S, Lecardeur L, Morello R, Etard O: Placebo response in repetitive transcranial magnetic stimulation trials of treatment of auditory hallucinations in schizophrenia: a meta-analysis. Schizophr Bull 2016; 42: 301–308.
  31. Bartoli F, Pompili M, Lillia N, Crocamo C, Salemi G, Clerici M, Carra G: Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis. J Neurol Neurosurg Psychiatry 2017; 88: 498–504.
  32. Bartoli F, Clerici M, Crocamo C, Carra G: Insomnia as an additional clinical correlate of suicidal ideation after stroke. Gen Hosp Psychiatry 2017, Epub ahead of print.
  33. Bartoli F, Lillia N, Lax A, Crocamo C, Mantero V, Carra G, Agostoni E, Clerici M: Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat 2013; 2013: 862978.
  34. Bartoli F, Paolucci S: Association of depression and SSRIs with mortality after stroke. Neurology 2014; 83: 1998–1999.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 07, 2017
Accepted: November 30, 2017
Published online: January 16, 2018
Issue release date: April 2018

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 2

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP